Give Up Board Chairmanship? No Thanks, US Big Pharma CEOs Say
October 16, 2019
Michelle Lowry, PhD, TD Bank Professor of Finance at the LeBow School of Business and academic director of the Raj & Kamla Gupta Governance Institute, was quoted in an Oct. 16 Biopharma Dive story about Pfizer becoming the only U.S.-based traditional big pharmaceutical company in which the CEO won't also serve as the chair of the company's board.
Related:
Drexel News is produced by
University Marketing and Communications.